Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
US Department of Justice
Teva
Deloitte
Daiichi Sankyo
US Army
QuintilesIMS
Cantor Fitzgerald
Julphar

Generated: January 18, 2018

DrugPatentWatch Database Preview

Dexbrompheniramine maleate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexbrompheniramine maleate and what is the scope of dexbrompheniramine maleate patent protection?

Dexbrompheniramine maleate
is the generic ingredient in seven branded drugs marketed by Schering, Copley Pharm, Avanthi Inc, Sandoz, Schering Plough, and Pioneer Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dexbrompheniramine maleate.

US Patents and Regulatory Information for dexbrompheniramine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Copley Pharm BROMPHERIL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 089116-001 Jan 22, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Avanthi Inc DEXBROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE SULFATE dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 078648-001 Feb 27, 2013 OTC No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering DISOMER dexbrompheniramine maleate SYRUP;ORAL 011814-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pioneer Pharms RESPORAL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 089139-001 Jun 16, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering DISOPHROL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET;ORAL 012394-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering Plough DRIXORAL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 013483-003 Sep 13, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering DISOMER dexbrompheniramine maleate TABLET;ORAL 011814-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering Plough DISOPHROL dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 013483-004 Sep 13, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz DISOBROM dexbrompheniramine maleate; pseudoephedrine sulfate TABLET, EXTENDED RELEASE;ORAL 070770-001 Sep 30, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Baxter
Farmers Insurance
Teva
Covington
Cerilliant
Queensland Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot